Dexcom reports third quarter financial results
Revenue grew 11% to $1.344 billion, operating income rose 420 basis points, and the company raised full-year guidance while announcing a $1 billion share repurchase authorization.
See the latest news and media coverage for Dexcom. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of continuous glucose monitoring systems
dexcom.comLast updated
In short: Dexcom published landmark CONNECT results, reported strong Q2 growth, and unveiled the G8 CGM at Investor Day.
Revenue grew 11% to $1.344 billion, operating income rose 420 basis points, and the company raised full-year guidance while announcing a $1 billion share repurchase authorization.
Operating income rose 590 basis points to 24.3% of revenue, and GAAP net income increased to $249.1 million.
Will add two independent directors with MedTech and operations experience, and reconstitute a committee to oversee operations, quality and technical roadmap. Initiatives follow engagement with Elliott Management.
Revenue grows 15% to $1.192 billion. Operating income rises to $255.3 million. Raises 2026 guidance. Expands Dexcom G7 launch.
Medical device company DexCom (NASDAQ:DXCM) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue ...
DexCom logged higher third-quarter sales and authorized a share-buyback program of up to $1 billion. The maker of glucose monitors posted a profit of $275.1...
Publication marks the first time in nearly two decades that The New England Journal of Medicine has published clinical data on standalone real-time continuous glucose...
DexCom raises its 2026 revenue and margin outlook as G7 15 Day efficiencies lift profitability,...
Track Dexcom and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.